Dexmedetomidine and Wide-Awake Local Anesthesia No Tourniquet (WALANT) technique

The value of local dexmedetomidine as an adjuvant to Wide-Awake Local Anesthesia No Tourniquet (WALANT) anesthesia in flexor tendon repair

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202307777479162

Enrollment

128

Registered

2023-07-31

Start date

2022-04-30

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

WALANT with dexmedetomidine

control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients of both sex aged more than 20 years old, diagnosed with a flexor tendon injury in the hand region, scheduled for surgical intervention under WALANT, and classified as class I or II according to the American Society of Anesthesiologists (ASA) physical status score

Exclusion criteria

Exclusion criteria: patients refusal of anesthesia technique, patients diagnosed with finger tendon lesions, bleeding diathesis, ASA class III or more, or had known allergies to any of the study medications patients with concomitant bony fractures or requiring digital nerve repair.

Design outcomes

Primary

Measure	Time frame
The total morphine consumption throughout the 1st post-operative day	—

Secondary

Measure	Time frame
time to first analgesic request	—

Countries

Egypt

Contacts

Public ContactElsayed Abdelkarime

mansoura university

elsayedabdelkarim@mans.edu.eg+201004965196

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026